INTERNATIONAL PATENT: F. HOFFMANN-LA ROCHE AG, HOFFMANN-LA ROCHE INC. FILES APPLICATION FOR "INHIBITION OF T-CELL ENGAGING AGENT-RELATED ADVERSE EFFECTS"

GENEVA, May 10 -- F. HOFFMANN-LA ROCHE AG (Grenzacherstrasse 1244070 Basel), HOFFMANN-LA ROCHE INC. (Overlook at Great Notch, 150 Clove Road8th Floor, Suite 8 - Legal DepartmentLittle Falls, New Jersey 07424) filed a patent application (PCT/EP2025/081049) for "INHIBITION OF T-CELL ENGAGING AGENT-RELATED ADVERSE EFFECTS" on Oct 28, 2025. With publication no. WO/2026/093255, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BACAC, Marina (c/o Roche Glycart AGWagistrasse 108952 Schlieren), LECLERCQ-COHEN, Gabrielle (c/o Roche ...